Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Lymphoma, T-Cell, Peripheral

abstract

  • Clinicaltrials.gov identifiers: NCT00426764, NCT00007345.

publication date

  • March 6, 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1080/10428194.2017.1295143

PubMed ID

  • 28264616

Additional Document Info

start page

  • 1

end page

  • 7